Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.38
-0.38 (-1.46%)
Streaming Delayed Price
Updated: 1:15 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
18,486,445
Open
25.75
Bid (Size)
25.37 (5,200)
Ask (Size)
25.38 (6,700)
Prev. Close
25.75
Today's Range
25.28 - 25.83
52wk Range
21.97 - 28.75
Shares Outstanding
5,606,688,356
Dividend Yield
6.78%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM
↗
Today 12:10 EDT
BioNTech (NASDAQ:BNTX) used its virtual annual general meeting to outline a transition year marked by leadership changes, continued investment in oncology, a planned share repurchase program and a...
Via
MarketBeat
Buy, Sell, or Hold Novo Nordisk at $46?
↗
Today 11:05 EDT
Can Novo Nordisk thrive under intense competitive pressures?
Via
The Motley Fool
Performance
YTD
+0.8%
+0.8%
1 Month
-6.4%
-6.4%
3 Month
-7.6%
-7.6%
6 Month
-1.6%
-1.6%
1 Year
+15.2%
+15.2%
More News
Read More
My Top 3 Healthcare Stocks for May 2026
↗
Today 8:53 EDT
Via
The Motley Fool
2 Ways to Play the Big Pharma Patent Cliff
↗
Today 7:05 EDT
Via
MarketBeat
Topics
ETFs
Intellectual Property
1 Stock Under $50 to Target This Week and 2 We Avoid
Today 0:32 EDT
Via
StockStory
Pfizer Just Locked In Its Next 5 Years of Growth -- Here's How
↗
May 14, 2026
Via
The Motley Fool
Topics
Intellectual Property
Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?
↗
May 14, 2026
Via
The Motley Fool
Valneva Q1 Earnings Call Highlights
↗
May 13, 2026
Via
MarketBeat
Topics
Earnings
These Analysts Increase Their Forecasts On Arvinas After Q1 Results
↗
May 13, 2026
Via
Benzinga
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally
↗
May 13, 2026
Via
The Motley Fool
3 Struggling Stocks That Could Make for Great Contrarian Buys
↗
May 13, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors
May 13, 2026
From
Pfizer Inc.
Via
Business Wire
The Top 5 Analyst Questions From Novavax’s Q1 Earnings Call
May 13, 2026
Via
StockStory
Topics
Earnings
Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer
↗
May 12, 2026
Via
Benzinga
Prediction: Pfizer Will Beat the Market Over the Next 5 Years
↗
May 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Up 373%, Is ExxonMobil Proving Why It Was a Mistake for Salesforce to Replace ExxonMobil in the Dow Jones Industrial Average?
↗
May 12, 2026
Via
The Motley Fool
Topics
Stocks
Arvinas Q1 Earnings Call Highlights
↗
May 12, 2026
Via
MarketBeat
Topics
Earnings
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026
Via
FinancialNewsMedia
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026
From
MarketNewsUpdates.com
Via
GlobeNewswire
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
May 12, 2026
From
Arvinas Inc.
Via
GlobeNewswire
Is Pfizer a Buy, Sell, or Hold in 2026?
↗
May 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Pfizer's Net Income Drops in Q1. Is Its Dividend Still Safe?
↗
May 12, 2026
Via
The Motley Fool
5 Must-Read Analyst Questions From Pfizer’s Q1 Earnings Call
May 12, 2026
Via
StockStory
Topics
Earnings
Is This a Sign Pfizer's Aggressive Growth Strategy Is Paying Off?
↗
May 11, 2026
Via
The Motley Fool
Topics
Intellectual Property
BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly
May 11, 2026
Via
Investor Brand Network
Frequently Asked Questions
Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 25.38
When was Pfizer last traded?
The last trade of Pfizer was at 05/15/26 01:15 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 142.27B
How many shares of Pfizer are outstanding?
Pfizer has 142B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.